Related Experiment Videos
[Gastric cancer-associated antigen P42]
Zhonghua Zhong Liu Za Zhi [Chinese Journal of Oncology]
|March 1, 1987
Summary
A novel protein, P42, was identified as a gastric cancer-associated antigen. Elevated P42 levels in patient sera suggest its potential for early cancer detection and screening.
Area of Science:
- Biochemistry
- Oncology
- Immunology
Context:
- Gastric cancer diagnosis relies on invasive procedures and lacks sensitive biomarkers for early detection.
- Monoclonal antibody PCI targets a specific antigen on gastric cancer cells.
- Understanding tumor-associated antigens is crucial for developing diagnostic tools.
Purpose:
- To identify and characterize the antigen recognized by monoclonal antibody PCI.
- To evaluate the potential of this antigen as a biomarker for gastric cancer detection.
Summary:
- A 42 kDa protein, designated P42, was identified as the antigen for monoclonal antibody PCI against gastric cancer cells.
- P42 is heat-sensitive and proteinase-degradable, and can be detected in patient sera.
- Serum levels of P42 were significantly higher in gastric cancer patients compared to those with benign gastric diseases and healthy controls.
Impact:
- P42 represents a novel biomarker for gastric cancer.
- This finding could lead to improved diagnostic strategies and mass screening for gastric cancer.
- Further research may validate P42's utility in clinical settings for early gastric cancer diagnosis.